» Articles » PMID: 29453740

Arrestins: Structural Disorder Creates Rich Functionality

Overview
Journal Protein Cell
Date 2018 Feb 18
PMID 29453740
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Arrestins are soluble relatively small 44-46 kDa proteins that specifically bind hundreds of active phosphorylated GPCRs and dozens of non-receptor partners. There are binding partners that demonstrate preference for each of the known arrestin conformations: free, receptor-bound, and microtubule-bound. Recent evidence suggests that conformational flexibility in every functional state is the defining characteristic of arrestins. Flexibility, or plasticity, of proteins is often described as structural disorder, in contrast to the fixed conformational order observed in high-resolution crystal structures. However, protein-protein interactions often involve highly flexible elements that can assume many distinct conformations upon binding to different partners. Existing evidence suggests that arrestins are no exception to this rule: their flexibility is necessary for functional versatility. The data on arrestins and many other multi-functional proteins indicate that in many cases, "order" might be artificially imposed by highly non-physiological crystallization conditions and/or crystal packing forces. In contrast, conformational flexibility (and its extreme case, intrinsic disorder) is a more natural state of proteins, representing true biological order that underlies their physiologically relevant functions.

Citing Articles

Do arrestin oligomers have specific functions?.

Gurevich V Cell Signal (Middlet). 2023; 1(1):42-46.

PMID: 37664541 PMC: 10473880. DOI: 10.46439/signaling.1.009.


Activation of insulin-like growth factor-1 receptor (IGF-1R) promotes growth of colorectal cancer through triggering the MEX3A-mediated degradation of RIG-I.

Xie Q, Chu Y, Yuan W, Li Y, Li K, Wu X Acta Pharm Sin B. 2023; 13(7):2963-2975.

PMID: 37521868 PMC: 10372823. DOI: 10.1016/j.apsb.2023.04.001.


Interactions between β-arrestin proteins and the cytoskeletal system, and their relevance to neurodegenerative disorders.

Szenasi T, Turu G, Hunyady L Front Endocrinol (Lausanne). 2023; 14:957981.

PMID: 36843600 PMC: 9947276. DOI: 10.3389/fendo.2023.957981.


Lighting up Nobel Prize-winning studies with protein intrinsic disorder.

Piersimoni L, Abd El Malek M, Bhatia T, Bender J, Brankatschk C, Calvo Sanchez J Cell Mol Life Sci. 2022; 79(8):449.

PMID: 35882686 PMC: 11072364. DOI: 10.1007/s00018-022-04468-y.


GPCR-mediated β-arrestin activation deconvoluted with single-molecule precision.

Asher W, Terry D, Gregorio G, Kahsai A, Borgia A, Xie B Cell. 2022; 185(10):1661-1675.e16.

PMID: 35483373 PMC: 9191627. DOI: 10.1016/j.cell.2022.03.042.


References
1.
Song X, Vishnivetskiy S, Gross O, Emelianoff K, Mendez A, Chen J . Enhanced arrestin facilitates recovery and protects rods lacking rhodopsin phosphorylation. Curr Biol. 2009; 19(8):700-5. PMC: 2768495. DOI: 10.1016/j.cub.2009.02.065. View

2.
Kook S, Zhan X, Kaoud T, Dalby K, Gurevich V, Gurevich E . Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding. J Biol Chem. 2013; 288(52):37332-42. PMC: 3873585. DOI: 10.1074/jbc.M113.510412. View

3.
Agarwal P . Role of protein dynamics in reaction rate enhancement by enzymes. J Am Chem Soc. 2005; 127(43):15248-56. DOI: 10.1021/ja055251s. View

4.
KOVOOR A, Celver J, Abdryashitov R, Chavkin C, Gurevich V . Targeted construction of phosphorylation-independent beta-arrestin mutants with constitutive activity in cells. J Biol Chem. 1999; 274(11):6831-4. DOI: 10.1074/jbc.274.11.6831. View

5.
Hanson S, Gurevich V . The differential engagement of arrestin surface charges by the various functional forms of the receptor. J Biol Chem. 2005; 281(6):3458-62. PMC: 2440687. DOI: 10.1074/jbc.M512148200. View